+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Increased dopamine D2High receptors in knockouts of the dopamine transporter and the vesicular monoamine transporter may contribute to spontaneous hyperactivity and dopamine supersensitivity



Increased dopamine D2High receptors in knockouts of the dopamine transporter and the vesicular monoamine transporter may contribute to spontaneous hyperactivity and dopamine supersensitivity



Synapse 61(7): 573-576




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053800931

Download citation: RISBibTeXText

PMID: 17447256

DOI: 10.1002/syn.20402


Related references

Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain. Plos One 7(11): E49483, 2013

Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Molecular Pharmacology 47(2): 368-373, 1995

Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons. Journal of Neurochemistry 111(5): 1202-1212, 2009

Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Annals of Neurology 40(3): 428-439, 1996

Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein. European Journal of Pharmacology 504(1-2): 27-32, 2004

Increased Vesicular Monoamine Transporter 2 (VMAT2) and Dopamine Transporter (DAT) Expression in Adolescent Brain Development: A Longitudinal Micro-PET/CT Study in Rodent. Frontiers in Neuroscience 12: 1052-1052, 2019

Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system. Journal of Pharmacology and Experimental Therapeutics 310(3): 1142-1151, 2004

Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors. Journal of Neuroscience 22(19): 8705-8710, 2002

Dopamine transporter and vesicular monoamine transporter knockout mice : implications for Parkinson's disease. Methods in Molecular Medicine 62: 179-190, 2001

The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat. Journal of Neuroscience 16(10): 3507-3510, 1996

Coordinated expression of dopamine transporter and vesicular monoamine transporter in the primate striatum during development. Synapse 67(9): 580-585, 2014

The Vesicular Monoamine Transporter, in Contrast to the Dopamine Transporter, Is Not Altered by Chronic Cocaine Self-Administration in the Rat. The Journal of Neuroscience 16(10): 3507-3510, 1996

The vesicular monoamine transporter, in contrast to the dopamine transporter, is not regulated following chronic cocaine self-administration. Society for Neuroscience Abstracts 21(1-3): 1382, 1995

The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate. European Neuropsychopharmacology 15(1): 95-101, 2004

Methylphenidate redistributes vesicular monoamine transporter-2 immunoreactivity Role of dopamine receptors. FASEB Journal 16(4): A585, March 20, 2002